RDGN-based predictive model for the prognosis of breast cancer

Abstract Background Breast cancer is the most diagnosed malignancy in females in the United States. The members of retinal determination gene network (RDGN) including DACH, EYA, as well as SIX families participate in the proliferation, apoptosis, and metastasis of multiple tumors including breast ca...

Full description

Bibliographic Details
Main Authors: Bing Dong, Ming Yi, Suxia Luo, Anping Li, Kongming Wu
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40164-020-00169-z
_version_ 1818137912168939520
author Bing Dong
Ming Yi
Suxia Luo
Anping Li
Kongming Wu
author_facet Bing Dong
Ming Yi
Suxia Luo
Anping Li
Kongming Wu
author_sort Bing Dong
collection DOAJ
description Abstract Background Breast cancer is the most diagnosed malignancy in females in the United States. The members of retinal determination gene network (RDGN) including DACH, EYA, as well as SIX families participate in the proliferation, apoptosis, and metastasis of multiple tumors including breast cancer. A comprehensive predictive model of RDGN might be helpful to herald the prognosis of breast cancer patients. Methods In this study, the Gene Expression Ominibus (GEO) and Gene Set Expression Analysis (GSEA) algorithm were used to investigate the effect of RDGN members on downstream signaling pathways. Besides, based on The Cancer Genome Atlas (TCGA) database, we explored the expression patterns of RDGN members in tumors, normal tissues, and different breast cancer subtypes. Moreover, we estimated the relationship between RDGN members and the outcomes of breast cancer patients. Lastly, we constructed a RDGN-based predictive model by Cox proportional hazard regression and verified the model in two separate GEO datasets. Results The results of GSEA showed that the expression of DACH1 was negatively correlated with cell cycle and DNA replication pathways. On the contrary, the levels of EYA2 and SIX1 were significantly positively correlated with DNA replication, mTOR, and Wnt pathways. Further investigation in TCGA database indicated that DACH1 expression was lower in breast cancers especially basal-like subtype. In the meanwhile, SIX1 was remarkably upregulated in breast cancers while EYA2 level was increased in Basal-like and Her-2 enriched subtypes. Survival analyses demonstrated that DACH1 was a favorable factor while EYA2 and SIX1 were risk factors for breast cancer patients. Given the results of Cox proportional hazard regression analysis, two members of RDGN were involved in the present predictive model and patients with high model index had poorer outcomes. Conclusion This study showed that aberrant RDGN expression was an unfavorable factor for breast cancer. This RDGN-based comprehensively framework was meaningful for predicting the prognosis of breast cancer patients.
first_indexed 2024-12-11T10:03:50Z
format Article
id doaj.art-db422e55efa84405be7ce965130f987a
institution Directory Open Access Journal
issn 2162-3619
language English
last_indexed 2024-12-11T10:03:50Z
publishDate 2020-06-01
publisher BMC
record_format Article
series Experimental Hematology & Oncology
spelling doaj.art-db422e55efa84405be7ce965130f987a2022-12-22T01:12:03ZengBMCExperimental Hematology & Oncology2162-36192020-06-019111210.1186/s40164-020-00169-zRDGN-based predictive model for the prognosis of breast cancerBing Dong0Ming Yi1Suxia Luo2Anping Li3Kongming Wu4Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Breast cancer is the most diagnosed malignancy in females in the United States. The members of retinal determination gene network (RDGN) including DACH, EYA, as well as SIX families participate in the proliferation, apoptosis, and metastasis of multiple tumors including breast cancer. A comprehensive predictive model of RDGN might be helpful to herald the prognosis of breast cancer patients. Methods In this study, the Gene Expression Ominibus (GEO) and Gene Set Expression Analysis (GSEA) algorithm were used to investigate the effect of RDGN members on downstream signaling pathways. Besides, based on The Cancer Genome Atlas (TCGA) database, we explored the expression patterns of RDGN members in tumors, normal tissues, and different breast cancer subtypes. Moreover, we estimated the relationship between RDGN members and the outcomes of breast cancer patients. Lastly, we constructed a RDGN-based predictive model by Cox proportional hazard regression and verified the model in two separate GEO datasets. Results The results of GSEA showed that the expression of DACH1 was negatively correlated with cell cycle and DNA replication pathways. On the contrary, the levels of EYA2 and SIX1 were significantly positively correlated with DNA replication, mTOR, and Wnt pathways. Further investigation in TCGA database indicated that DACH1 expression was lower in breast cancers especially basal-like subtype. In the meanwhile, SIX1 was remarkably upregulated in breast cancers while EYA2 level was increased in Basal-like and Her-2 enriched subtypes. Survival analyses demonstrated that DACH1 was a favorable factor while EYA2 and SIX1 were risk factors for breast cancer patients. Given the results of Cox proportional hazard regression analysis, two members of RDGN were involved in the present predictive model and patients with high model index had poorer outcomes. Conclusion This study showed that aberrant RDGN expression was an unfavorable factor for breast cancer. This RDGN-based comprehensively framework was meaningful for predicting the prognosis of breast cancer patients.http://link.springer.com/article/10.1186/s40164-020-00169-zBreast cancerRDGNDACHEYASIXPredictive model
spellingShingle Bing Dong
Ming Yi
Suxia Luo
Anping Li
Kongming Wu
RDGN-based predictive model for the prognosis of breast cancer
Experimental Hematology & Oncology
Breast cancer
RDGN
DACH
EYA
SIX
Predictive model
title RDGN-based predictive model for the prognosis of breast cancer
title_full RDGN-based predictive model for the prognosis of breast cancer
title_fullStr RDGN-based predictive model for the prognosis of breast cancer
title_full_unstemmed RDGN-based predictive model for the prognosis of breast cancer
title_short RDGN-based predictive model for the prognosis of breast cancer
title_sort rdgn based predictive model for the prognosis of breast cancer
topic Breast cancer
RDGN
DACH
EYA
SIX
Predictive model
url http://link.springer.com/article/10.1186/s40164-020-00169-z
work_keys_str_mv AT bingdong rdgnbasedpredictivemodelfortheprognosisofbreastcancer
AT mingyi rdgnbasedpredictivemodelfortheprognosisofbreastcancer
AT suxialuo rdgnbasedpredictivemodelfortheprognosisofbreastcancer
AT anpingli rdgnbasedpredictivemodelfortheprognosisofbreastcancer
AT kongmingwu rdgnbasedpredictivemodelfortheprognosisofbreastcancer